As a medical professional, you may come across patients who experience severe physical and emotional symptoms in the days leading up to their menstrual cycle. While some may brush it off as regular PMS, others could be suffering from Premenstrual Dysphoric Disorder (PMDD). PMDD is a more severe form of premenstrual syndrome that affects approximately 5% of menstruating women. As someone who cares for the wellbeing of your patients, it's important to understand what PMDD is, how it's diagnosed, and what treatments are available. In this blog post, we'll dive into all things PMDD so you can provide the best care possible for those who suffer from this disorder.
PMDD symptoms can vary from person to person, but typically include a combination of physical and emotional symptoms. Physical symptoms may include breast tenderness, bloating, headaches, joint pain, and fatigue. Emotional symptoms are often more severe than those experienced with PMS and may include mood swings, irritability, anxiety or tension that can interfere with daily activities.
The emotional symptoms associated with PMDD can be extremely disruptive to a woman's life. Mood swings and depression can cause difficulty in the workplace or at home. Intense anger or feelings of hopelessness could lead to suicidal thoughts.
Symptoms typically occur about one week before menstruation begins and improve once menstruation starts. If your patient experiences these types of changes on a monthly basis it’s important they seek medical attention as there is no need for them suffer through this alone!
When it comes to treating PMDD, there are several options available depending on the severity of symptoms and the individual’s preferences. First and foremost, lifestyle changes such as regular exercise and a healthy diet can help alleviate some symptoms.
For those who need additional support, antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or hormonal birth control may be prescribed. Both types of medication have been shown to effectively reduce PMDD symptoms in many individuals.
Other alternative treatments include cognitive-behavioral therapy (CBT) or other forms of talk therapy, which can help manage stress levels and address underlying mental health concerns that may contribute to PMDD.
PMDD is a very real and debilitating condition that affects many women. As medical professionals, it's important to be aware of the symptoms and how to properly diagnose and treat PMDD. By understanding this disorder, we can improve the quality of life for our patients who are dealing with these difficult symptoms.
By staying informed about new research on the topic of PMDD, we can continue to provide better care for our patients who suffer from this disorder. Let's work together towards creating a brighter future where all women have access to effective treatments for PMDD.
1.
Charles III, King of Kings, is Cancerous.
2.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
3.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
4.
Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.
5.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
1.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
2.
Ultimate Guide to Oncology Services in the USA
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
5.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation